Drug Discovery 아웃소싱 시장 규모 : 워크플로우, 치료 영역ㅍ약제 유형, 최종사용자별 - 지역별 전망, 경쟁 전략, 부문 예측(-2033년)

Drug Discovery Outsourcing Market Introduction and Overview

According to SPER market research, Drug Discovery Outsourcing Market Size- By Workflow, By Therapeutic Area, By Drug Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033 state that the Drug Discovery Outsourcing Market is predicted to reach USD 8.59 billion by 2033 with a CAGR of 7.71%.

One way to uncover new medications or therapeutics in a variety of sectors, including pharmacology, biotechnology, and pharmaceuticals, is through drug discovery outsourcing. This approach has a relatively poor success rate in drug development and is a labor-intensive procedure. Nonetheless, both large and tiny producers in the industry create novel medications and provide them to well-known competitors for examination after clinical trials to determine and guarantee the medications' efficacy.

Because several pharmaceutical and biotech businesses have been in high demand for vaccine discovery over the last three years, COVID-19 has had a substantial influence on the drug discovery industry. Using outside help for drug research has become essential to creating potent anti-virus therapies. Because businesses in the biotech and pharmaceutical sectors were progressively outsourcing research efforts to CROs, COVID-19 had a major effect on the market's growth. These operations comprised basic research employing in vitro and in vivo models as well as early-stage clinical development.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Workflow, By Therapeutic Area, By Drug Type, By End User.

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Charles River Laboratories, Curia Global Inc, Dalton Pharma Service, Discover X Corporation, Dr. Reddy's Laboratories, Laboratory Corporation of America Holdings, Merck & Co, Syngene Intentional Ltd, Thermo Fisher Scientific,Inc, TCG Life Science Pvt Ltd.

Drug Discovery Outsourcing Market Segmentation

By Workflow: Based on the Workflow, Global Drug Discovery Outsourcing Market is segmented as; Target Validation and Functional Informatics, Lead Identification and Candidate Optimization, Preclinical Development, Target Identification and Screening, Others.

By Therapeutic Area: Based on the Therapeutic Area, Global Drug Discovery Outsourcing Market is segmented as; Cardiovascular, Central Nervous System, Gastrointestinal, Hematology, Respiration System, Infectious Disease, Oncology, Immunology, Others

By Drug Type: Based on the Drug Type, Global Drug Discovery Outsourcing Market is segmented as; Small Molecules, Large Molecules.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPER's internal database
  • 2.1.4. Premium insight from KOL's
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges
• 4.2. COVID-19 Impacts of the Global Drug Discovery Outsourcing Market.

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTER's Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Drug Discovery Outsourcing Market Manufacturing Base Distribution, Sales Area, Product Type
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Drug Discovery Outsourcing Market

7. Global Drug Discovery Outsourcing Market, By Workflow(USD Million) 2020-2033

• 7.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2020-2026
• 7.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2027-2033
• 7.3. Target Validation and Functional Informatics
• 7.4. Lead Identification and Candidate Optimization
• 7.5. Preclinical Development
• 7.6. Target Identification and Screening
• 7.7. Others

8. Global Drug Discovery Outsourcing Market, By Therapeutic Area(USD Million) 2020-2033

• 8.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2020-2026)
• 8.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2027-2033)
• 8.3. Cardiovascular
• 8.4. Central Nervous System
• 8.5. Gastrointestinal
• 8.6. Haematology
• 8.7. Respiratory System
• 8.8. Infectious Disease
• 8.9. Oncology
• 8.10. Immunology
• 8.11. Others

9. Global Drug Discovery Outsourcing Market, By Drug Type (USD Million) 2020-2033

• 9.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2020-2026)
• 9.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2027-2033)
• 9.3. Small Molecules
• 9.4. Large Molecules

10. Global Drug Discovery Outsourcing Market, By End User (USD Million) 2020-2033

• 10.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2020-2026)
• 10.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2027-2033)
• 10.3. Pharmaceutical and Biotechnological Companies
• 10.4. Academia Institutions
• 10.5. Others

11. Global Drug Discovery Outsourcing Market Forecast, 2020-2033 (USD Million)

• 11.1. Global Drug Discovery Outsourcing Market Size and Market Share

12. Global Drug Discovery Outsourcing Market, By Region, 2020-2033 (USD Million)

• 12.1. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2020-2026)
• 12.2. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2027-2033)
• 12.3. Asia-Pacific
  • 12.3.1. Australia
  • 12.3.2. China
  • 12.3.3. India
  • 12.3.4. Japan
  • 12.3.5. South Korea
  • 12.3.6. Rest of Asia-Pacific
• 12.4. Europe
  • 12.4.1. France
  • 12.4.2. Germany
  • 12.4.3. Italy
  • 12.4.4. Spain
  • 12.4.5. United Kingdom
  • 12.4.6. Rest of Europe
• 12.5. Middle East and Africa
  • 12.5.1. Kingdom of Saudi Arabia
  • 12.5.2. United Arab Emirates
  • 12.5.3. Qatar
  • 12.5.4. South Africa
  • 12.5.5. Egypt
  • 12.5.6. Morocco
  • 12.5.7. Nigeria
  • 12.5.8. Rest of Middle-East and Africa
• 12.6. North America
  • 12.6.1. Canada
  • 12.6.2. Mexico
  • 12.6.3. United States
• 12.7. Latin America
  • 12.7.1. Argentina
  • 12.7.2. Brazil
  • 12.7.3. Rest of Latin America

13. Company Profile

• 13.1. Charles River Laboratories
  • 13.1.1. Company details
  • 13.1.2. Financial outlook
  • 13.1.3. Product summary
  • 13.1.4. Recent developments
• 13.2. Curia Global Inc.
  • 13.2.1. Company details
  • 13.2.2. Financial outlook
  • 13.2.3. Product summary
  • 13.2.4. Recent developments
• 13.3. Dalton Pharma Service
  • 13.3.1. Company details
  • 13.3.2. Financial outlook
  • 13.3.3. Product summary
  • 13.3.4. Recent developments
• 13.4. Dr. Reddy's Laboratories
  • 13.4.1. Company details
  • 13.4.2. Financial outlook
  • 13.4.3. Product summary
  • 13.4.4. Recent developments
• 13.5. Discover X Corporation
  • 13.5.1. Company details
  • 13.5.2. Financial outlook
  • 13.5.3. Product summary
  • 13.5.4. Recent developments
• 13.6. Laboratory Corporation of America
  • 13.6.1. Company details
  • 13.6.2. Financial outlook
  • 13.6.3. Product summary
  • 13.6.4. Recent developments
• 13.7. Merck & Co
  • 13.7.1. Company details
  • 13.7.2. Financial outlook
  • 13.7.3. Product summary
  • 13.7.4. Recent developments
• 13.8. Syngene International Ltd.
  • 13.8.1. Company details
  • 13.8.2. Financial outlook
  • 13.8.3. Product summary
  • 13.8.4. Recent developments
• 13.9. TCG Life Science Pvt. Ltd.
  • 13.9.1. Company details
  • 13.9.2. Financial outlook
  • 13.9.3. Product summary
  • 13.9.4. Recent developments
• 13.10. Thermo Fisher Scientific, Inc.
  • 13.10.1. Company details
  • 13.10.2. Financial outlook
  • 13.10.3. Product summary
  • 13.10.4. Recent developments
• 13.11. Others

14. List of Abbreviations

15. Reference Links

16. Conclusion

17. Research Scope